Cardiovascular Hazards of Abacavir- Versus Tenofovir-Containing Antiretroviral Therapies: Insights From an Analysis of the REPRIEVE Trial Cohort

By sjmartinez • April 10, 2025

Davies Smith E, Malvestutto C, Ribaudo HJ, Fichtenbaum CJ, Aberg JA, Watanabe M, Bloomfield GS, Currier JS, Chu SM, Fitch KV, Diggs MR, Bedimo R, Valencia J, Gomez-Ayerbe C, Brar I, Madruga JV, Lu MT, Douglas PS, Zanni MV, Grinspoon SK. Cardiovascular Hazards of Abacavir- Versus Tenofovir-Containing Antiretroviral Therapies: Insights From an Analysis of the REPRIEVE Trial Cohort. Open Forum Infect Dis. 2025 Mar 21;12(4):ofaf177. doi: 10.1093/ofid/ofaf177. PMID: 40207047; PMCID: PMC11979587.

Tags: abacavir, antiretroviral therapy, Infectious Diseases, major adverse cardiovascular events, Publications, REPRIEVE, Tenofovir

Non-viable Aspergillus fumigatus promotes chronic inflammation and angiogenesis in a murine fungus ball model

Hamashima R, Tashiro M, Nakano Y, Shirahige T, Namie H, Yano H, Ito Y, Yoshida M, Hirayama T, Takeda K, Iwanaga N, Kakiuchi S, Nishi[...]

Doxycycline-Induced Phototoxicity Localized to Vitiligo-Affected and Sun-Exposed Skin

Dong S, Harris C, Ly A, Lee PS. Doxycycline-Induced Phototoxicity Localized to Vitiligo-Affected and Sun-Exposed Skin. Cureus. 2026 Feb 17;18(2):e103789. doi: 10.7759/cureus.103789. PMID: 41869147; PMCID:[...]

“It’s being uncomfortable for who you are, because I think HIV is part of me … “: psychosocial adaptation and treatment engagement among GBMSM older and younger than 30 years engaged in a coping and disclosure skills intervention in the Eastern Cape, South Africa

de Vos L, Rutt K, Metula A, Peters RPH, Bongo C, Daniels J. "It's being uncomfortable for who you are, because I think HIV is[...]